Filing Flows › Harvard Bioscience (HBIO) › Instruments, Equipment, Software, and Accessories revenue
Harvard Bioscience (HBIO) Instruments, Equipment, Software, and Accessories revenue by quarter
Harvard Bioscience's Instruments, Equipment, Software, and Accessories revenue was $20.3M in Q2 2026 (second quarter 2026), +9% from Q1 2026. Over the last 7 quarters it ranged from $18.2M (Q2 2025) to $22.4M (Q4 2024).
| Quarter | Instruments, Equipment, Software, and Accessories revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $20.3M | +9% | +12% |
| Q1 2026 | $18.6M | -14% | -7% |
| Q4 2025 | $21.6M | +16% | -3% |
| Q3 2025 | $18.6M | +2% | — |
| Q2 2025 | $18.2M | -8% | — |
| Q1 2025 | $19.9M | -11% | — |
| Q4 2024 | $22.4M | — | — |
Q2 2026 at a glance
Harvard Bioscience, Q2 2026: revenue $22.7M (+11% year over year), operating margin -4.3%, net loss $2.9M, operating cash flow $325K. The chart follows the revenue to costs, profit and cash.
Questions
What is Harvard Bioscience's Instruments, Equipment, Software, and Accessories revenue?
Harvard Bioscience's Instruments, Equipment, Software, and Accessories revenue was $20.3M in Q2 2026 (second quarter 2026), +9% from Q1 2026.
How has Harvard Bioscience's Instruments, Equipment, Software, and Accessories revenue changed?
Over the last 7 quarters it ranged from $18.2M (Q2 2025) to $22.4M (Q4 2024).